NATIONAL HEALTHCARE CORP

Insider Trading & Executive Data

NHC
NYSEMKT
Healthcare
Medical Care Facilities

Start Free Trial

Get the full insider signal for NHC

108 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
108
6 in last 30 days
Buy / Sell (1Y)
42/66
Acquisitions / Dispositions
Unique Insiders (1Y)
13
Active in past year
Insider Positions
29
Current holdings
Position Status
26/3
Active / Exited
Institutional Holders
207
Latest quarter
Board Members
25

Compensation & Governance

Avg Total Compensation
$1.1M
Latest year: 2024
Executives Covered
6
Comp records available
Form 8-K Events (1Y)
3
Personnel Changes (1Y)
3
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
2
Board Appointments (1Y)
2
Board Departures (1Y)
1

Restricted Sales

Form 144 Filings (1Y)
0
Form 144 Insiders (1Y)
0
Planned Sale Shares (1Y)
0
Planned Sale Value (1Y)
$0.00
Price
$163.69
Market Cap
$2.5B
Volume
1,287
EPS
$7.67
Revenue
$1.5B
Employees
15.0K
About NATIONAL HEALTHCARE CORP

Company Overview

National HealthCare Corporation (NHC) is a vertically integrated post-acute and senior care operator that runs skilled nursing facilities, assisted and independent living communities, home health and hospice agencies, and a small behavioral health hospital footprint, supplemented by pharmacy, captive insurance and management services. As of year‑end 2024 NHC operated 80 SNFs (10,341 licensed beds), 26 assisted living communities, 9 independent living communities, 34 homecare agencies and 33 hospice agencies, and generated ~95.7% of revenues from healthcare services with a payor mix of ~33% Medicare, 29% Medicaid and 28% private pay. Recent strategic activity includes the August 1, 2024 White Oak acquisition (15 SNFs, 2 AL, 4 IL) and materially higher per‑diems and occupancy (composite SNF per diem +6.8% in 2024; SNF occupancy ~88.6%), while regulatory drivers include FY2025/FY2026 CMS rate actions and phased minimum nurse‑staffing mandates.

Executive Compensation Practices

Compensation is likely tied to a blend of financial and clinical performance measures that reflect NHC’s operating model—key drivers being adjusted net income/adjusted EPS, operating cash flow, per‑diem rate realization, SNF occupancy and margin improvement (including reductions in agency nursing expense). Given management’s repeated use of non‑GAAP metrics in disclosures, annual cash incentives and bonus targets are likely calibrated to adjusted results (excluding one‑time acquisition and investment mark‑to‑market items) and integration milestones for acquisitions like White Oak. Long‑term pay typically includes equity (restricted stock/RSUs and/or performance shares) to align executives with total shareholder return and multi‑year quality goals (e.g., CMS star ratings and rehospitalization/clinical metrics); workforce and retention concerns (high wage/benefit spend ~62% of revenues) mean retention bonuses, tuition reimbursement and other non‑cash retention measures are also important. Regulatory and actuarial uncertainties (self‑insurance reserves, professional liability accruals) create scope for comp plan clawbacks or performance adjustments and may lead the board to emphasize cash flow and reserve management in incentive design.

Insider Trading Considerations

Insiders’ trading patterns at NHC are likely influenced by discrete operational catalysts (M&A activity such as the White Oak acquisition), periodic CMS and state Medicaid rate announcements, and quarter/annual earnings that hinge on occupancy and per‑diem trends. Watch for insider purchases when occupancy, per‑diems and agency cost improvements accelerate (a bullish signal), and for sizable insider sales around acquisition closings, dividend/share‑repurchase communications or ahead of financing actions; conversely, reductions in reserves or adverse litigation/cybersecurity events could prompt sales or defensive disclosure. Because healthcare is highly regulated, expect routine blackout periods around Form 10‑Q/10‑K and material rulemaking announcements, broad use of 10b5‑1 plans among executives, and careful linking of reported non‑GAAP adjustments to incentive outcomes—traders should monitor Section 16 filings closely around reimbursement rule changes, state Medicaid decisions, and large integration milestones.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for NATIONAL HEALTHCARE CORP and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime